Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1LUNDBECK PHARMS LLC

02 2LUPIN

03 1MELINTA

04 1MERCK SHARP DOHME

05 1SAGE THERAP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLundbeck CDM delivers end-to-end API and drug product solutions from development to commercial scale.

Patent Expiration Date : 2029-03-13

CARBAMAZEPINE

US Patent Number : 9750822

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206030

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-13

Company Banner

02

FOSPHENYTOIN SODIUM

US Patent Number : 9750822

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210864

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-13

blank

03

FOSPHENYTOIN SODIUM

US Patent Number : 9750822

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 210864

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-13

blank

04

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

DELAFLOXACIN MEGLUMINE

US Patent Number : 9750822

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 208611

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-13

blank

05

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

POSACONAZOLE

US Patent Number : 9750822

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 205596

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-13

blank

06

arrow
BioProcess International US West
Not Confirmed
arrow
BioProcess International US West
Not Confirmed

BREXANOLONE

US Patent Number : 9750822

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 211371

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-03-13

blank